Alex Fässler
Fortuna: 3 M $ al 30/06/2026
Fortuna: 3 M $ al 30/06/2026
Alex Fässler is currently the Head of Operations at Targimmune Therapeutics AG.
Previously, he worked as the Chief Operating Officer at Bachem Holding AG and as the Head of Production & Site Manager at Bachem AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 33.580 ( 0,04 % ) | 3 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Director de Operaciones | - |
| Empresas | Cargo | Fin |
|---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Corporate Officer/Principal | - |
| BACHEM HOLDING AG | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Bachem Holding AG
Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.